1.Shock Management in Patient with Heart Failure and Sepsis: The Role of Hemodynamic Assessment
Anak Agung Ngurah Agung Pradnya Iswara Wirawan ; I Gusti Agung Ngurah Krishna Dvaipayana Puja ; Luh Oliva Saraswati Suastika
Malaysian Journal of Medicine and Health Sciences 2026;22(Supp 1):20-23
Sepsis is a life-threatening organ dysfunction resulting from a dysregulated host response to infection. Septic shock, a
severe subset of sepsis, must be promptly recognized and managed as a medical emergency. We present the case of
a 51-year-old male who developed shock during hospitalization for infected leg ulcers, with a background of chronic
heart failure (HF), hypertension, and poorly controlled type 2 diabetes mellitus. Despite his history of HF, bedside
echocardiography revealed low systemic vascular resistance and preserved cardiac output, findings more consistent
with septic shock than cardiogenic shock. This case underscores the pivotal role of early hemodynamic assessment,
particularly with echocardiography, in accurately identifying the type of shock in patients with pre-existing HF. Differentiating the underlying etiology is essential to initiate appropriate therapy and improve clinical outcomes.
2.Elinzanetant: Defining the Role of Dual Neurokinin-1 and Neurokinin-3 Receptor Antagonism for Management of Vasomotor Symptoms in Menopause
Journal of Menopausal Medicine 2026;32(1):57-60
Menopausal vasomotor symptoms (VMS) represent a significant public health burden, necessitating safe and effective nonhormonal treatments. The recent US Food and Drug Administration approval of elinzanetant, a first-in-class dual neurokinin-1 (NK1) and neurokinin-3 (NK3) receptor antagonist, represents a major shift and warrants a critical assessment of its role. VMS pathogenesis centers on the hypothalamic KNDy neuron network and is primarily mediated by Neurokinin B acting on the NK3 receptor. Elinzanetant’s distinctive dual mechanism, simultaneously blocking NK3 (VMS control) and NK1 (mood and sleep modulation), translates into improved patient outcomes as demonstrated across the OASIS Phase 3 program. Specifically, elinzanetant achieved a 65.2%–67.0% reduction in VMS frequency by Week 12 (OASIS 1/2) and produced clinically meaningful improvement in the PROMIS SD-SF 8b sleep disturbance score. While indirect cross-over study comparisons with fezolinetant (NK3 antagonist) suggest a numerical advantage in sleep quality for elinzanetant, head-to-head trials are required for confirmation. The drug demonstrated sustained efficacy and a favorable long-term liver safety profile, making it strategically important for the general population. Elinzanetant represents a major shift in the nonhormonal treatment approach, offering a safe and sustained alternative for managing menopausal symptoms.
3.Tear Film Inflammatory Biomarkers in Keratoconus: Insights into Disease Severity and Diagnostic Potential
SreeLakshmi PALLAMREDDY ; Sandhya CHEEDELLA ; Murali Krishna DAMDAMRAJU ; Madhusudana PULAGANTI
Korean Journal of Ophthalmology 2026;40(2):125-132
Purpose:
Keratoconus (KC) involves a progressive corneal deformation, recognized as having an inflammatory component, despite traditionally being considered noninflammatory. This study investigates the notable tear film cytokines and their correlation with KC disease severity. The objectives of this study were to measure inflammatory tear biomarkers in KC patients and to compare them with healthy controls and to evaluate biomarker levels across different severity stages of KC. This study follows a case-control observational design, comparing inflammatory tear biomarkers in KC patients (cases) and healthy individuals (controls), at a single point in time without intervention.
Methods:
Eighteen KC patients and 25 healthy individuals were enrolled. Tear samples were collected via Schirmer strips and analyzed for interleukin (IL)-1β, IL-4, IL-6, IL-10, matrix metalloproteinase 9 (MMP-9), and tumor necrosis factor α (TNF-α) using ELISA. Group comparisons were made using nonparametric tests, and Spearman correlation evaluated associations with disease severity.
Results:
KC patients showed significantly elevated levels of IL-1β, IL-4, IL-6, IL-10, MMP-9, and TNF-α (p < 0.05). IL-1β, MMP-9, and TNF-α demonstrated strong associations with disease severity, while IL-6 and IL-10 exhibited moderate correlations, and IL-4 showed only a weak association with KC progression.
Conclusions
The study emphasizes inflammation’s role in KC and identifies tear film inflammatory markers as promising tools for diagnosis, prognosis, early detection, disease monitoring, and personalized treatment.
4.Surgical Management of Paraganglioma of the Organ of Zuckerkandl with Combined Resection of the Aorta and Inferior Vena Cava with Bifurcation: A Case Report
Shalini Shree KRISHNAMURTHY ; Saravanan MOORTHY ; Krishna MURALIDHARAN ; Anand RAJA
Vascular Specialist International 2025;41(1):3-
Paragangliomas are rare neuroendocrine tumors that frequently arise in the organ of Zuckerkandl (OZ). Surgical resection remains the cornerstone of treatment. Although vascular resection and reconstruction have been reported in a few cases, no prior reports have documented the simultaneous resection of both the aorta and inferior vena cava (IVC), along with their bifurcation. We present the case of a 50-year-old man with a large paraganglioma of the OZ, successfully managed through combined resection of the aorta, IVC, their bifurcation, and the psoas muscle. Dacron Y-grafts were used to reconstruct both the aorta and IVC. This case underscores the importance of detailed anatomical knowledge of major vessels, meticulous vascular control, and the technical intricacies of vascular reconstruction. We emphasize the significance of comprehensive perioperative management and provide a literature review on en bloc vascular resection for paraganglioma, offering insights into current surgical practices and outcomes.
5.Anatomical variation of quadratus plantae with flexor digitorum longus tendon along with unilateral polydactyly of the toes: a rare case report
Hare KRISHNA ; Rahul GAUR ; Sarthak GUPTA ; Surajit GHATAK
Anatomy & Cell Biology 2025;58(1):132-135
During routine dissection, we observed a unique case of unilateral polydactyly in the left foot of a 61-year-old male cadaver. We observed the medial head of the quadratus plantae (QP) muscle, which gave off an additional tendinous slip before joining the lateral head of QP. The 4th tendon of the flexor digitorum longus (FDL) was bifurcated into two tendinous parts after receiving a thin fibrous slip from the tendinous slip of the medial head of QP. The medial division of the 4th tendon of FDL passed forward and attached to the base of the distal phalanx of the 5th toe. The extra tendinous slip from the medial head of QP was attached distally to the lateral division of the 4th tendon of FDL and formed a common anomalous tendon to the 6th toe. The knowledge of this variation would be helpful in reconstructive foot surgeries and correction of congenital deformities.
6.Anatomical variation of quadratus plantae with flexor digitorum longus tendon along with unilateral polydactyly of the toes: a rare case report
Hare KRISHNA ; Rahul GAUR ; Sarthak GUPTA ; Surajit GHATAK
Anatomy & Cell Biology 2025;58(1):132-135
During routine dissection, we observed a unique case of unilateral polydactyly in the left foot of a 61-year-old male cadaver. We observed the medial head of the quadratus plantae (QP) muscle, which gave off an additional tendinous slip before joining the lateral head of QP. The 4th tendon of the flexor digitorum longus (FDL) was bifurcated into two tendinous parts after receiving a thin fibrous slip from the tendinous slip of the medial head of QP. The medial division of the 4th tendon of FDL passed forward and attached to the base of the distal phalanx of the 5th toe. The extra tendinous slip from the medial head of QP was attached distally to the lateral division of the 4th tendon of FDL and formed a common anomalous tendon to the 6th toe. The knowledge of this variation would be helpful in reconstructive foot surgeries and correction of congenital deformities.
7.Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report
Pramod KUMAR ; Pradeep KRISHNA ; Rohit MAIDUR ; Naveen CHANDRASHEKHAR ; Suresh RAGHAVAIAH
Journal of Liver Cancer 2025;25(1):134-137
Hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) is associated with a dismal prognosis. Atezolizumab plus bevacizumab (atezo-bev) is the recommended palliative treatment, and approximately 10% of the patients may experience a complete response (CR), according to the mRECIST criteria. The treatment duration is until disease progression or unacceptable side effects occur. Long-term continuation can cause potential toxicities and a substantial financial burden, making early treatment discontinuation a viable option. This report describes durable CR after discontinuing atezo-bev treatment in three patients with HCC and PVTT.
8.Recanalization Outcomes and Procedural Complications in Patients With Acute Ischemic Stroke and COVID-19 Receiving Endovascular Treatment
João Pedro MARTO ; Davide STRAMBO ; George NTAIOS ; Thanh N NGUYEN ; Pawel WRONA ; Simon ESCALARD ; Simona MARCHESELLI ; Ossama Yassin MANSOUR ; Blanca FUENTES ; Malgorzata DOROBEK ; Marta NOWAKOWSKA-KOTAS ; Elena Oana TERECOASA ; Jonathan M. COUTINHO ; Mariana CARVALHO-DIAS ; Patricia CALLEJA ; João SARGENTO-FREITAS ; Ana PAIVA-NUNES ; Martin ŠRÁMEK ; Priyank KHANDELWAL ; Torcato MEIRA ; Mohamad ABDALKADER ; Pascal JABBOUR ; Martin KOVÁŘ ; Oscar AYO-MARTIN ; Patrik MICHEL ; Roman HERZIG ; Anna CZŁONKOWKSA ; Jelle DEMEESTERE ; Raul G. NOGUEIRA ; Alexander SALERNO ; Susanne WEGENER ; Philipp BAUMGARTNER ; Carlo W. CEREDA ; Giovanni BIANCO ; Morin BEYELER ; Marcel ARNOLD ; Emmanuel CARRERA ; Paolo MACHI ; Valerian ALTERSBERGER ; Leo BONATI ; Henrik GENSICKE ; Manuel BOLOGNESE ; Nils PETERS ; Stephan WETZEL ; Marta MAGRIÇO ; João NUNO RAMOS ; Rita MACHADO ; Carolina MAIA ; Egídio MACHADO ; Patrícia FERREIRA ; Teresa PINHO-E-MELO ; André PAULA ; Manuel Alberto CORREIA ; Pedro CASTRO ; Elsa AZEVEDO ; Luís ALBUQUERQUE ; José NUNO-ALVES ; Joana FERREIRA-PINTO ; Torcato MEIRA ; Liliana PEREIRA ; Miguel RODRIGUES ; André ARAÚJO ; Marta RODRIGUES ; Mariana ROCHA ; Ângelo PEREIRA-FONSECA ; Luís RIBEIRO ; Ricardo VARELA ; Sofia MALHEIRO ; Manuel CAPPELLARI ; Cecilia ZIVELONGHI ; Giulia SAJEVA ; Andrea ZINI ; Gentile MAURO ; Forlivesi STEFANO ; Ludovica MIGLIACCIO ; Maria SESSA ; Sara La GIOIA ; Alessandro PEZZINI ; Davide SANGALLI ; Marialuisa ZEDDE ; Rosario PASCARELLA ; Carlo FERRARESE ; Simone BERETTA ; Susanna DIAMANTI ; Ghil SCHWARZ ; Giovanni FRISULLO ; Pierre SENERS ; Candice SABBEN ; Michel PIOTIN ; Benjamin MAIER ; Guillaume CHARBONNIER ; Fabrice VUILLIER ; Loic LEGRIS ; Pauline CUISENIER ; Francesca R. VODRET ; Gaultier MARNAT ; Jean-Sebastien LIEGEY ; Igor SIBON ; Fabian FLOTTMANN ; Gabriel BROOCKS ; Nils-Ole GLOYER ; Ferdinand O. BOHMANN ; Jan Hendrik SCHAEFER ; Christian H. NOLTE ; Heinrich AUDEBERT ; Eberhard SIEBERT ; Marek SYKORA ; Wilfried LANG ; Julia FERRARI ; Lukas MAYER-SUESS ; Michael KNOFLACH ; Elke-Ruth GIZEWSKI ; Jeffrey STOLP ; Lotte J. STOLZE ; Paul J. NEDERKOORN ; Ido VAN-DEN-WIJNGAARD ; Joke DE MERIS ; Robin LEMMEN ; Sylvie DE RAEDT ; Fenne VANDERVORST ; Matthieu Pierre RUTGERS ; Antoine GUILMOT ; Anne DUSART ; Flavio BELLANTE ; Fernando OSTOS ; Guillermo GONZALEZ-ORTEGA ; Paloma MARTÍN-JIMÉNEZ ; Sebastian GARCÍA-MADRONA ; Antonio CRUZ-CULEBRAS ; Rocio VERA ; Maria-Consuelo MATUTE ; María ALONSO-DE-LECIÑANA ; Ricardo RIGUAL ; Exuperio DÍEZ-TEJEDOR ; Soledad PÉREZ-SÁNCHEZ ; Joan MONTANER ; Fernando DÍAZ-OTERO ; Natalia PEREZ-DE-LA-OSSA ; Belén FLORES-PINA ; Lucia MUÑOZ-NARBONA ; Angel CHAMORRO ; Alejandro RODRÍGUEZ-VÁZQUEZ ; Arturo RENÚ ; Francisco HERNANDEZ-FERNANDEZ ; Tomas SEGURA ; Herbert TEJADA-MEZA ; Daniel SAGARRA-MUR ; Marta SERRANO-PONZ ; Thant HLAING ; Isaiah SEE ; Robert SIMISTER ; David J. WERRING ; Espen Saxhaug KRISTOFFERSEN ; Annika NORDANSTIG ; Katarina JOOD ; Alexandros RENTZOS ; Libor ŠIMU˚NE ; Dagmar KRAJÍČKOVÁ ; Antonín KRAJINA ; Robert MIKULÍK ; Martina CVIKOVÁ ; Jan VINKLÁREK ; David ŠKOLOUDÍK ; Martin ROUBEC ; Eva HURTIKOVA ; Rostislav HRUBÝ ; Svatopluk OSTRY ; Ondrej SKODA ; Marek PERNICKA ; Lubomír KOČÍ ; Zuzana EICHLOVÁ ; Martin JÍRA ; Michal PANSKÝ ; Pavel MENCL ; Hana PALOUŠKOVÁ ; Aleš TOMEK ; Petr JANSKÝ ; Anna OLŠEROVÁ ; Roman HAVLÍČEK ; Petr MALÝ ; Lukáš TRAKAL ; Jan FIKSA ; Matěj SLOVÁK ; Michał KARLIŃSK ; Maciej NOWAK ; Halina SIENKIEWICZ-JAROSZ ; Anna BOCHYNSKA ; Tomasz HOMA ; Katarzyna SAWCZYNSKA ; Agnieszka SLOWIK ; Ewa WLODARCZYK ; Marcin WIĄCEK ; Izabella TOMASZEWSKA-LAMPART ; Bartosz SIECZKOWSKI ; Halina BARTOSIK-PSUJEK ; Marta BILIK ; Anna BANDZAREWICZ ; Justyna ZIELIŃSKA-TUREK ; Krystian OBARA ; Paweł URBANOWSKI ; Sławomir BUDREWICZ ; Maciej GUZIŃSKI ; Milena ŚWITOŃSKA ; Iwona RUTKOWSKA ; Paulina SOBIESZAK-SKURA ; Beata ŁABUZ-ROSZAK ; Aleksander DĘBIEC ; Jacek STASZEWSKI ; Adam STĘPIEŃ ; Jacek ZWIERNIK ; Grzegorz WASILEWSKI ; Cristina TIU ; Razvan-Alexandru RADU ; Anca NEGRILA ; Bogdan DOROBAT ; Cristina PANEA ; Vlad TIU ; Simona PETRESCU ; Atilla ÖZCAN-ÖZDEMIR ; Mostafa MAHMOUD ; Hussam EL-SAMAHY ; Hazem ABDELKHALEK ; Jasem AL-HASHEL ; Ismail IBRAHIM ISMAIL ; Athari SALMEEN ; Abdoreza GHOREISHI ; Sergiu SABETAY ; Hana GROSS ; Piers KLEIN ; Kareem EL NAAMANI ; Stavropoula TJOUMAKARIS ; Rawad ABBAS ; Ghada-A MOHAMED ; Alex CHEBL ; Jiangyong MIN ; Majesta HOVINGH ; Jenney-P TSAI ; Muhib-A KHAN ; Krishna NALLEBALLE ; Sanjeeva ONTEDDU ; Hesham-E MASOUD ; Mina MICHAEL ; Navreet KAUR ; Laith MAALI ; Michael ABRAHAM ; Ivo BACH ; Melody ONG ; Denis BABICI ; Ayaz-M. KHAWAJA ; Maryam HAKEMI ; Kumar RAJAMANI ; Vanessa CANO-NIGENDA ; Antonio ARAUZ ; Pablo AMAYA ; Natalia LLANOS ; Akemi ARANGO ; Miguel A. VENCES ; José-Domingo BARRIENTOS ; Rayllene CAETANO ; Rodrigo TARGA ; Sergio SCOLLO ; Patrick YALUNG ; Shashank NAGENDRA ; Abhijit GAIKWAD ; Kwon-Duk SEO ;
Journal of Stroke 2025;27(1):128-132
9.Andrology laboratory techniques for micro-TESE/IVF/ICSI: a narrative review.
Krishna Chaitanya MANTRAVADI ; Christina ANAGNOSTOPOULOU ; Firuza R PARIKH
Asian Journal of Andrology 2025;27(3):383-391
Since the early days of assisted reproductive technology (ART), the importance of sperm processing, employed to separate the motile, morphologically normal sperm from the semen, has been shown to be beneficial. The aim of the semen processing technique has been to remove seminal plasma and facilitate capacitation. Additionally, the presence of leukocytes, bacteria, and dead spermatozoa has been shown to be detrimental as it may cause oxidative stress that has an adverse effect on oocyte fertilization and embryo development. Hence, removal of leukocytes, bacteria, and dead spermatozoa is an important step of sperm processing for assisted reproduction. Currently, several sperm processing techniques have been evolved and optimized in the field of assisted reproduction. The requirements for in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and testicular sperm extraction (TESE) are different than those of intrauterine insemination (IUI). The yield of as many motile, morphologically normal sperm as possible is a prerequisite for the success of IVF insemination procedure. In ICSI, where injection of a single spermatozoon into the oocyte is performed by the embryologist, sperm selection techniques play a crucial role in the ICSI procedure. Finally, sperm retrieval in TESE samples with very low number of sperm may be challenging and requires extra care during sample processing. Additionally, sperm cryopreservation is necessary in TESE cases in order to avoid multiple biopsies.
Humans
;
Sperm Injections, Intracytoplasmic/methods*
;
Male
;
Fertilization in Vitro/methods*
;
Sperm Retrieval
;
Andrology/methods*
;
Cryopreservation
;
Female
;
Spermatozoa
10.Fresh versus frozen micro-TESE sperm and outcomes.
Krishna Chaitanya MANTRAVADI ; Marlon MARTINEZ ; Favian Ariiq RAHMAT ; Armand ACHMADSYAH ; Missy SAVIRA ; Ponco BIROWO
Asian Journal of Andrology 2025;27(3):399-408
The use of fresh versus frozen spermatozoa in men with nonobstructive azoospermia (NOA) undergoing in vitro fertilization (IVF) has been a debated hot topic among reproductive specialists. Each approach presents distinct advantages and disadvantages, with fresh sperm typically showing superior sperm quality, while frozen sperm offers logistical flexibility and a reliable backup for repeated cycles. This review summarizes the latest advancements in sperm retrieval and cryopreservation techniques, providing practitioners with a comprehensive analysis of each option's strengths and limitations. Comparative studies indicate that, although fresh sperm often has better quality metrics, cryopreservation methods such as vitrification have significantly improved postthaw outcomes, making frozen sperm a viable choice in assisted reproductive technologies (ART). The findings show comparable rates for fertilization, implantation, clinical pregnancy, and live birth between fresh and frozen microdissection testicular sperm extraction (micro-TESE) sperm in many cases, although patient-specific factors such as timing, cost-effectiveness, and procedural convenience should guide the final decision. Ultimately, the choice of using fresh or frozen sperm should align with the individual needs and conditions of patients. This tailored approach, supported by the latest advancements, can optimize ART outcomes and provide personalized reproductive care.
Humans
;
Cryopreservation/methods*
;
Male
;
Sperm Retrieval
;
Semen Preservation/methods*
;
Azoospermia/therapy*
;
Pregnancy
;
Female
;
Fertilization in Vitro
;
Spermatozoa
;
Microdissection
;
Pregnancy Rate


Result Analysis
Print
Save
E-mail